Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MD.0000000000008402 http://scihub22266oqcxt.onion/10.1097/MD.0000000000008402 C5671870!5671870 !29069037     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29069037 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Medicine+(Baltimore) 2017 ; 96 (43 ): e8402 Nephropedia Template TP {{tp|p=29069037 |t=2017. Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis |pdf=|usr=}}{{29069037 }} gab.com Text Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis JO: Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=29069037 #FOAvip BACKGROUND: Guidelines recommend that norepinephrine (NA) should be used to reach the target mean arterial pressure (MAP) during cardiogenic shock (CS), rather than epinephrine and dopamine (DA). However, there has actually been few studies on comparing norepinephrine with dopamine and their results conflicts. These studies raise a heat discussion. This study aimed to validate the effectiveness of norepinephrine for treating CS in comparison with dopamine. METHODS: We performed a meta-analysis of randomized controlled trials (RCTs) to assess pooled estimates of risk ratio (RR) and 95% confidence interval (CI) for 28-day mortality, incidence of arrhythmic events, gastrointestinal reaction, and some indexes after treatment. RESULTS: Compared with dopamine, patients receiving norepinephrine had a lower 28-day mortality (RR 1.611 [95% CI 1.219-2.129]; P?<?.001; P heterogeneity?=?.01), a lower risk of arrhythmic events (RR 3.426 [95% CI 2.120-5.510]; P?<?.001; P heterogeneity?=?.875) and a lower risk of gastrointestinal reaction (RR 5.474 [95% CI 2.917-10.273]; P?<?.001; P heterogeneity?=?0). In subgroup analyses on 28-day mortality by causes of CS, there were more benefits from norepinephrine than dopamine in 2 subgroups. CONCLUSIONS: Our analysis revealed that norepinephrine was associated with a lower 28-day mortality, a lower risk of arrhythmic events, and gastrointestinal reaction. No matter whether CS is caused by coronary heart disease or not, norepinephrine is superior to dopamine for correcting CS on the 28-day mortality. Twit Text FOAVip Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis ????Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=29069037 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29069037 #FOAvip English Wikipedia <ref>{{Cite pmid|29069037 }}</ref> Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis #MMPMID29069037 Rui Q ; Jiang Y ; Chen M ; Zhang N ; Yang H ; Zhou Y Medicine (Baltimore) 2017[Oct]; 96 (43 ): e8402 PMID29069037 show ga BACKGROUND: Guidelines recommend that norepinephrine (NA) should be used to reach the target mean arterial pressure (MAP) during cardiogenic shock (CS), rather than epinephrine and dopamine (DA). However, there has actually been few studies on comparing norepinephrine with dopamine and their results conflicts. These studies raise a heat discussion. This study aimed to validate the effectiveness of norepinephrine for treating CS in comparison with dopamine. METHODS: We performed a meta-analysis of randomized controlled trials (RCTs) to assess pooled estimates of risk ratio (RR) and 95% confidence interval (CI) for 28-day mortality, incidence of arrhythmic events, gastrointestinal reaction, and some indexes after treatment. RESULTS: Compared with dopamine, patients receiving norepinephrine had a lower 28-day mortality (RR 1.611 [95% CI 1.219-2.129]; P? |Cardiotonic Agents/*therapeutic use [MESH] |Dopamine/*therapeutic use [MESH] |Humans [MESH] |Norepinephrine/*therapeutic use [MESH] |Odds Ratio [MESH] |Randomized Controlled Trials as Topic [MESH] |Shock, Cardiogenic/*drug therapy/etiology/mortality [MESH]Dopamine versus norepinephrine in the treatment of cardiogenic shock: (epmc).pdf DeepDyve Pubget Overpricing